Ando Miki

Profile Information

Affiliation: Chief Professor, Department of Hematology, Juntendo University Graduate School of Medicine

Degree: 医学博士(順天堂大学)

J-GLOBAL ID: 201801009412872474
researchmap Member ID: B000296547

Research Areas

Life sciences / Hematology and oncology /

Awards

Nov, 2018

同窓会学術奨励賞, 順天堂大学医学部

安藤美樹
Jun, 2016

ISSCR 2016 Annual Meeting Travel Award, Induced Pluripotent Stem Cell-Derived Rejuvenated T-Cell Therapy with Suicide Gene-based Safeguard System, ISSCR

Ando Miki
Sep, 2015

第７回血液疾患免疫療法研究会学術集会優秀演題賞(平成２７年９月), ウイルス関連腫瘍に対するiPS細胞由来若返りCTL療法の臨床応用実現への試み, 血液疾患免疫療法研究会学術集会

安藤美樹
Jan, 2015

Excellent Poster Award, The Safeguard System for Rejuvenated T cell Immunotherapy

Ando Miki

Major Papers

iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer

Yoshiki Furukawa, Midori Ishii, Jun Ando, Kazuya Ikeda, Kyomi J. Igarashi, Shintaro Kinoshita, Yoko Azusawa, Tokuko Toyota, Tadahiro Honda, Mahito Nakanishi …

Cell Reports Medicine, Dec, 2023 Peer-reviewedLast authorCorresponding author
Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing

Yoshiki Furukawa, Yasuharu Hamano, Shuichi Shirane, Shintaro Kinoshita, Yoko Azusawa, Jun Ando, Hiromitsu Nakauchi, Miki Ando

Cells, 11(2) 269-269, Jan 13, 2022 Peer-reviewedInvitedLast authorCorresponding author
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma

Sakiko Harada, Miki Ando, Jun Ando, Midori Ishii, Tomoyuki Yamaguchi, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Manami Ohtaka, Mahito Nakanishi …

Molecular Therapy, 30(2) 534-549, Oct, 2021 Peer-reviewedCorresponding author
SCLC-J1, a novel small cell lung cancer cell line

Kazuo Ohara, Shintaro Kinoshita, Jun Ando, Yoko Azusawa, Midori Ishii, Sakiko Harada, Yoichiro Mitsuishi, Tetsuhiko Asao, Ken Tajima, Taketsugu Yamamoto …

Biochemistry and Biophysics Reports, 27 101089-101089, Sep, 2021 Peer-reviewedLast authorCorresponding author
iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma

Midori Ishii, Jun Ando, Satoshi Yamazaki, Tokuko Toyota, Kazuo Ohara, Yoshiki Furukawa, Yoshiyuki Suehara, Mahito Nakanishi, Kazutaka Nakashima, Koichi Ohshima …

Cancer Immunology Research, 9(10) 1175-1186, Aug 12, 2021 Peer-reviewedLast authorCorresponding author
Trigenic ADH5/ALDH2/ADGRV1 mutations in myelodysplasia with Usher syndrome

Shintaro Kinoshita, Miki Ando, Jun Ando, Midori Ishii, Yoshiki Furukawa, Osamu Tomita, Yoko Azusawa, Shuichi Shirane, Yoshihito Kishita, Yukiko Yatsuka …

Heliyon, 7(8) e07804-e07804, Aug, 2021 Peer-reviewedCorresponding author
Persistent immune thrombocytopaenic purpura associated with SARS-Cov-2 infection

Yoshiki Furukawa, Miki Ando, Yoko Azusawa, Shintaro Kinoshita, Sakiko Harada, Tomonori Ochiai, Tadahiro Honda, Kazuya Sugimoto, Yoko Tabe, Norio Komatsu …

eJHaem, Apr, 2021 Peer-reviewedCorresponding author
Sustainable tumor suppressive effect of iPSC-derived rejuvenated T cells targeting cervical cancers

Tadahiro Honda, Miki Ando, Jun Ando, Midori Ishii, Yumi Sakiyama, Kazuo Ohara, Tokuko Toyota, Manami Ohtaka, Ayako Masuda, Yasuhisa Terao …

Molecular Therapy, 28(11) 2394-2405, Jul, 2020 Peer-reviewedCorresponding author
Identification of protective T-cell antigens for smallpox vaccines

Jun Ando, Minhtran C. Ngo, Miki Ando, Ann Leen, Cliona M. Rooney

Cytotherapy, 22(11) 642-652, May, 2020 Peer-reviewed
iPSC-derived Rejuvenated T-cell Therapy for Extranodal NK/T-cell Lymphoma, Nasal Type

MIKI ANDO, JUN ANDO, TADAHIRO HONDA, MIDORI ISHII, HIROMITSU NAKAUCHI, NORIO KOMATSU

Juntendo Medical Journal, 66(3) 200-205, 2020 Peer-reviewedInvitedLead authorCorresponding author
Long-term eradication of extranodal NK/T cell lymphoma, nasal type, by iPSC-derived Epstein-Barr virus - specific rejuvenated T cells in vivo.

Miki Ando, Jun Ando, Satoshi Yamazaki, Midori Ishii, Yumi Sakiyama, Sakiko Harada, Tadahiro Honda, Tomoyuki Yamaguchi, Masanori Nojima, Koichi Ohshima …

Haematologica, 105(3) 796-807, Jul, 2019 Peer-reviewedLead authorCorresponding author
iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas.

Ando M, Nakauchi H, Komatsu N

Rinsho Ketsueki, 59(7) 932-938, 2018 Peer-reviewedInvitedLead authorCorresponding author
Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+T Cell Clones of Sjogren's Syndrome

Mana Iizuka-Koga, Hiromitsu Asashima, Miki Ando, Chen-Yi Lai, Shinji Mochizuki, Mahito Nakanishi, Toshinobu Nishimura, Hiroto Tsuboi, Tomoya Hirota, Hiroyuki Takahashi …

STEM CELL REPORTS, 8(5) 1155-1163, May, 2017 Peer-reviewed
'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes

Miki Ando, Hiromitsu Nakauchi

EXPERIMENTAL HEMATOLOGY, 47 2-12, Mar, 2017 Peer-reviewedLead authorCorresponding author
Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives

Go Itakura, Soya Kawabata, Miki Ando, Yuichiro Nishiyama, Keiko Sugai, Masahiro Ozaki, Tsuyoshi Iida, Toshiki Ookubo, Kota Kojima, Rei Kashiwagi …

STEM CELL REPORTS, 8(3) 673-684, Mar, 2017 Peer-reviewed
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy

Miki Ando, Toshinobu Nishimura, Satoshi Yamazaki, Tomoyuki Yamaguchi, Ai Kawana-Tachikawa, Tomonari Hayama, Yusuke Nakauchi, Jun Ando, Yasunori Ota, Satoshi Takahashi …

STEM CELL REPORTS, 5(4) 597-608, Oct, 2015 Peer-reviewedLead author
Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers

Valentina Hoyos, Francesca Del Bufalo, Shigeki Yagyu, Miki Ando, Gianpietro Dotti, Masataka Suzuki, Lisa Bouchier-Hayes, Ramon Alemany, Malcolm K. Brenner

MOLECULAR THERAPY, 23(9) 1497-1506, Sep, 2015 Peer-reviewed
Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity

M. Ando, V. Hoyos, S. Yagyu, W. Tao, C. A. Ramos, G. Dotti, M. K. Brenner, L. Bouchier-Hayes

CANCER GENE THERAPY, 21(11) 472-482, Nov, 2014 Peer-reviewedLead author
Selective apoptosis of natural killer-cell tumours by L-asparaginase

M Ando, K Sugimoto, T Kitoh, M Sasaki, K Mukai, J Ando, M Egashira, SM Schuster, K Oshimi

BRITISH JOURNAL OF HAEMATOLOGY, 130(6) 860-868, Sep, 2005 Peer-reviewedLead author
Mononucleosis syndrome and acute monocytic leukemia

K Tamayose, K Sugimoto, M Ando, K Oshimi

EUROPEAN JOURNAL OF HAEMATOLOGY, 68(4) 236-238, Apr, 2002 Peer-reviewed
Secondary myelodysplastic syndrome after treatment of prostate cancer with oral estramustine

M Ando, K Tamayose, K Sugimoto, K Oshimi

AMERICAN JOURNAL OF HEMATOLOGY, 67(4) 274-275, Aug, 2001 Peer-reviewedLead author
Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts

K Tamayose, K Sugimoto, M Ando, K Oshimi

BLOOD, 97(8) 2524-2524, Apr, 2001 Peer-reviewed

Misc.

難治性EBウイルス関連リンパ腫に対するiPS細胞由来LMP1-CART療法の開発

原田早希子, 安藤美樹, 安藤純, 山口智之, 山崎聡, 石井翠, 本田匡宏, 小原一男, 豊田釈子, 中沢洋三 …

Cytometry Research, 29(Suppl.) 64-64, May, 2019
iPS細胞由来CTLのCD8β鎖の解析(The role of CD8β-chain in iPSC-derived rejuvenated CTL therapy)

本田匡宏, 安藤美樹, 崎山祐未, 村越勇人, 安藤純, 滝口雅文, 中内啓光, 小松則夫

臨床血液, 59(9) 1517-1517, Sep, 2018
Control of immune microenvironment in tumor EBウイルス関連リンパ腫に対するiPS細胞由来若返りT細胞療法

安藤美樹, 中内啓光, 小松則夫

臨床血液, 59(7) 932-938, Jul, 2018
安全システムを兼ね備えたiPS細胞由来若返りT細胞療法の前臨床試験

安藤美樹, 安藤美樹, 石井翠, 石井翠, 崎山祐未, 渡部素生, 山崎聡, 山口智之, 西村聡修, 安藤純 …

再生医療, 16 347, Feb 1, 2017
ICOVIR-15 and Inducible Caspase-9 Delivered By Mesenchymal Stromal Cells (MSCs) for Lung Cancer Treatment

Valentina Hoyos, Shigeki Yagyu, Miki Ando, Francesca Del Bufalo, Wade Tao, Carlos Ramos, Gianpietro Dotti, Ramon Alemany, Malcolm K. Brenner

MOLECULAR THERAPY, 22 S65-S66, May, 2014
同種造血幹細胞移植後に皮膚生検でサルコイドーシスと診断した2例

金光奈緒子, 浜埜康晴, 中村紘子, 八幡悠里子, 稲垣直子, 安藤美樹, 杉本耕一, 小松則夫

日本造血細胞移植学会総会プログラム・抄録集, 34th 282, Feb 1, 2012
Changes in cell morphology and cytoskeletal organization are induced by human mitotic checkpoint gene, Bub1

Juntendo medical journal, 54(3) 401-402, Sep, 2008

Books and Other Publications

Molecular Players in iPSC Technology

Ando M, Kinoshita S, Furukawa Y, Ando J, Nakauchi H, Brenner MK (Role: Contributor, Improving the safety of iPSC-derived T cell therapy, Chapter 3)

Elsevier, Sep, 2021

Research Projects

Interdisciplinary research on autophagy: From working principles to pathophysiology

Grants-in-Aid for Scientific Research, Fund for the Promotion of Joint International Research (International Leading Research ), Japan Society for the Promotion of Science, Nov, 2023 - Mar, 2030
子宮頸がんに対するiPSC由来キメラ抗原受容体T細胞療法の有効性の検討

科学研究費助成事業, 基盤研究(C), 日本学術振興会, Apr, 2021 - Mar, 2024

安藤純, 安藤美樹, 寺尾泰久
The efficacy and safety of iPSC-derived CART therapy for small cell lung cancer

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, Apr, 2019 - Mar, 2022

Ando Miki
The development of immune cell therapy using iPSC-derived T cells targeting refractory cervical cancers

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, Apr, 2018 - Mar, 2021

ANDO JUN
The development of iPSC-derived CTL therapy for EBV-associated lymphoma

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, Apr, 2016 - Mar, 2020

Ando Miki
ｉＰＳ細胞由来ＣＴＬ療法における自殺遺伝子ｉＣａｓｐａｓｅ９による安全性確保

科学研究費助成事業, 特別研究員奨励費, 日本学術振興会, Apr, 2015 - Mar, 2016

安藤美樹

Profile Information

Research Areas

Awards

Major Papers

Misc.

Books and Other Publications

Research Projects

Menu

Coauthors